Consensus EPS · Q1 2026
$1.91
Consensus revenue · Q1 2026
$6.9B
Analysts
16
Expected report
May 7, 2026
Analyst consensus (locked)
Analyst consensus
Based on estimates from 16 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $6.8B | $6.9B | $7.1B |
| EPS | $1.74 | $1.91 | $2.06 |
| EBITDA | $2.4B | $2.4B | $2.5B |
| EBIT | $1.8B | $1.8B | $1.8B |
| Net income | $2.2B | $2.4B | $2.5B |
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q4 2025 | $7.9B | $7.7B | +3.0% | $1.86 | $1.81 | +2.8% |
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Gilead Sciences (GILD) Q1 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 4 analysts.
| Low | Consensus | Median | High | Current | Upside |
|---|---|---|---|---|---|
| $122.00 | $159.56 | $162.50 | $180.00 | $129.16 | +23.5% |
Upside calculated vs most recent trading price of $129.16.
Analyst ratings
Consensus: Buy — based on 58 analyst ratings.
12-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 20, 2026 | Maxim Group | upgrade | Hold | Buy |
| May 8, 2026 | Truist Securities | maintain | Buy | Buy |
| May 8, 2026 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Apr 13, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 10, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 23, 2026 | Needham | maintain | Buy | Buy |
| Feb 11, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 11, 2026 | Truist Securities | maintain | Buy | Buy |
| Feb 11, 2026 | Scotiabank | maintain | Sector Outperform | Sector Outperform |
| Feb 11, 2026 | RBC Capital | maintain | Sector Perform | Sector Perform |
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Frequently asked questions
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation